Granotapide
Granotapide is an orally active microsomal triglyceride transfer protein (MTP) inhibitor. Granotapide reduces the absorption of cholesterol and triglycerides by inhibiting MTP. Granotapide can be used in the research of coronary artery disease, obesity, diabetes mellitus and hypertension.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 594842-13-4
- Formel: C39H37F3N2O8
- Molecular Weight:718.71
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
Granotapide reduces the absorption of cholesterol and triglycerides by inhibiting MTP[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 594842-13-4
-
Molecular Weight 718.71
-
Formel C39H37F3N2O8
-
SMILES
CCOC(C(C(OCC)=O)(COC(CC1=CC(C(N(C)C)=O)=C(C=C1)NC(C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)=O)=O)C4=CC=CC=C4)=O
-
Synonyms
JTT-130
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)